| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avadel Pharmaceuticals Plc (AVDL) has 6 insiders with recent SEC Form 4 filings, including 11 buys and 2 sells. AVDL is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 115.1K | - | - | |
| Dir | 22.0K | - | - | |
| Dir | 22.0K | - | - | |
| Dir | 11.0K | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2018 | Divis Greg J71 | See Remarks | Buy | 16,000 | $6.00 | $96,000.00 | +48.3% | |
| Jun 26, 2018 | Thompson Phillandas T. | See Remarks | Buy | 10,000 | $5.77 | $57,700.00 | +12.3% | |
| Jun 25, 2018 | Flynn James E62 | 10% Owner, *possible Member Of 10% Group | Sell | 114,034 | $5.99 | $683,314.53 | -10.7% | |
| May 24, 2018 | Anderson Michael S | Chief Executive Officer | Buy | 3,000 | $6.44 | $19,320.00 | +1.2% | |
| Dec 7, 2017 | Anderson Michael S | Chief Executive Officer | Buy | 5,000 | $8.86 | $44,295.00 | +2.2% | |
| Nov 27, 2017 | Stapleton Craig R | Director | Sell | 254,265 | $9.35 | $2,377,632.02 | -50.1% | |
| Sep 21, 2017 | Thornton Peter J. | Director | Buy | 5,155 | $9.74 | $50,214.85 | New | |
| Sep 14, 2017 | Hatten Sandra L | See Remarks | Buy | 6,000 | $9.25 | $55,524.90 | +5.7% | |
| Sep 13, 2017 | Thompson Phillandas T. | See Remarks | Buy | 5,000 | $9.36 | $46,800.00 | +8.6% | |
| Sep 12, 2017 | Divis Greg J71 | See Remarks | Buy | 10,600 | $9.32 | $98,760.20 | New |